Jayasankar Narayanan

21 papers receiving 1.1k citations

Jayasankar Narayanan's Hit Papers

Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation 2023 · 768 citations
7680+1+2Years since publication250500750

Peers

Jayasankar Narayanan
Comparison fields: 5 of 87
  • Drug Discovery 10
  • Biomaterials 396
  • Rehabilitation 119
  • Pharmaceutical Science 89
  • Molecular Medicine 45
Replace Reza Mahmoudi with:
Reza Mahmoudi Iran
Xingmei Duan China
Chang Su China
Liqing Chen China
Hajra Zafar China
Chih-En Chou Taiwan
Ariana Hudiță Romania
Noyel Ghosh India
Qingchang Chen China
Fatemeh Kalalinia Iran
Jayasankar Narayanan relative to Reza Mahmoudi Iran Reza Mahmoudi's profile →
Citations per field
00.5×2×3×4×4.9×
Reza Mahmoudi · 1×
Citations per year

Countries citing papers authored by Jayasankar Narayanan

Since Specialization
Citations

This map shows the geographic impact of Jayasankar Narayanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayasankar Narayanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayasankar Narayanan more than expected).

Fields of papers citing papers by Jayasankar Narayanan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jayasankar Narayanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayasankar Narayanan. The network helps show where Jayasankar Narayanan may publish in the future.

Co-authors

The 25 scholars most cited alongside Jayasankar Narayanan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jayasankar Narayanan Line = papers co-authored together Jayasankar Narayanan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation
Hit paper breakdown →
2023768
2 2023134
3 202389
4 202427
5 202317
6 202414
7 201810
8 202410
9 20238
10 20247
11
A pan-cancer analysis of HAVCR1 with a focus on diagnostic, prognostic and immunological roles in human cancers.
20236
12 20246
13 20175
14 20205
15 20184
16 20204
17 20254
18 20213
19 20252
20 20241

About Jayasankar Narayanan

Jayasankar Narayanan is a scholar working on Pharmaceutical Science, Rehabilitation, Biomaterials, Pharmacology and Neurology, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Wound Healing and Treatments (3 papers), Advanced Drug Delivery Systems (2 papers), Computational Drug Discovery Methods (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Advancements in Transdermal Drug Delivery (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers) and Phytochemicals and Antioxidant Activities (1 paper). The work is most often cited by research in Drug Discovery (10 citations), Biomaterials (396 citations), Rehabilitation (119 citations), Pharmaceutical Science (89 citations) and Molecular Medicine (45 citations). Jayasankar Narayanan has collaborated with scholars based in India, Saudi Arabia and Malaysia. Frequent co-authors include Manimaran Vasanthan, Omer Qutaiba B. Allela, Mohamed J. Saadh, Renzon Daniel Cosme Pecho, Mohammad Chehelgerdi, Tamilanban Thamaraikani, Patrik Viktor, Reza Akhavan‐Sigari, Ali H. Amin and Mabrouk A. Abo‐Zaid. Their work appears in journals such as Pharmaceuticals, Archives of Microbiology, Biochemical and Biophysical Research Communications, Indian Journal of Pharmaceutical Education and Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact